Radius Health Gains 1%

Radius Health Gains 1%

Radius Health advanced in premarket trading on Wednesday after the biopharmaceutical company said positive results from a planned 6-month interim analysis of the ACTIVExtend clinical trial were published in the Mayo Clinic Proceedings. The results of ACTIVExtend following 6 months of alendronate treatment show that patients previously treated with daily abaloparatide-SC for 18 months in the ACTIVE trial who were transitioned to alendronate had significantly greater reduction of 87% in […]

Read More ˃
Illumina Posts Q4 Beat

Illumina Posts Q4 Beat

Shares of Illumina were up after hours Tuesday after the company reported Q4 results which were better-than-expected, guided FY17 earnings in line while issuing downside guidance for Q1. Q4 adjusted EPS was $0.85 per share, up from $0.81 per share a year earlier and two cents above the consensus. Revenues rose 5% year-over-year to $619 million and were above expectations for $618.8 million. For Q1, the provider of genetic sequencing […]

Read More ˃
H.B. Fuller Buys Wisdom Worldwide Adhesives

H.B. Fuller Buys Wisdom Worldwide Adhesives

H.B. Fuller, an adhesives provider, said pre-market Monday it purchased the industrial adhesives business of Wisdom Worldwide Adhesives, an adhesives provider. The business was purchased for $122 million and is expected to generate annual run rate synergies of $6 million starting in 2018. H.B. Fuller expects the transaction to be modestly accretive to earnings in the first year. “The acquisition will strengthen our leading position in this market segment within […]

Read More ˃
Pfizer Says Xeljanz Gets Positive Opinion From European Drug Agency

Pfizer Says Xeljanz Gets Positive Opinion From European Drug Agency

Pfizer said early Friday a committee at the European Medicines Agency adopted a positive opinion while recommending Xeljanz for the treatment of patients with moderate to severe active rheumatoid arthritis (RA). Shares drifted slightly higher in pre-market trading. The marketing-authorisation application included data from the oral rheumatoid arthritis phase 3 trials global development program in RA, according to a statement. This program consisted of six completed clinical trials, in addition […]

Read More ˃
North American Energy Partners Wins Contract

North American Energy Partners Wins Contract

North American Energy Partners said late Wednesday it has been awarded an overburden removal contract that is expected to generate over $45 million in revenue in fiscal 2017. “This award is also significant in that it will be the first overburden removal work we have done on this particular site in several years,” CEO Martin Ferron said. “We plan to ramp-up this work in the seasonally slow second quarter and […]

Read More ˃